CSF beta-endorphins in childhood neuropsychiatric disorders (Q44914300)

7 December 2017

title

CSF beta-endorphins in childhood neuropsychiatric disorders (English)

1 reference

7 December 2017

0 references

1

Gillberg C

1 reference

7 December 2017

Terenius L

2

1 reference

7 December 2017

Hagberg B

series ordinal

3

1 reference

7 December 2017

Witt-Engerström I

series ordinal

4

1 reference

7 December 2017

Eriksson I

series ordinal

5

1 reference

7 December 2017

publication date

1 January 1990

1 reference

7 December 2017

published in

Brain and Development

1 reference

7 December 2017

volume

12

1 reference

7 December 2017

issue

1

1 reference

7 December 2017

page(s)

88-92

1 reference

Ontogeny of Dopamine and Serotonin Metabolites in the Cerebrospinal Fluid of Children with Neurological Disorders

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Childhood psychosis and monoamine metabolites in spinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Cerebrospinal fluid indoleacetic acid in autistic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Neurochemical study of dopamine functioning in autistic and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Endorphin activity in childhood psychosis. Spinal fluid levels in 24 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Rett syndrome in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Diagnostic criteria for Rett syndrome. The Rett Syndrome Diagnostic Criteria Work Group

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Electrophoresis of opioid peptides on columns with agarose suspension

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Brain opioids and autism: an updated analysis of possible linkages

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Urinary homovanillic acid levels of autistic children

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Rett syndrome: spinal cord neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Cerebrospinal fluid values for monoamine metabolites, gamma-aminobutyric acid, and other amino compounds in Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Reduction of biogenic amine levels in the Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2812%2980185-9

7 January 2021

10.1016/S0387-7604(12)80185-9

Identifiers

DOI

0 references

1 reference